DB17185InvestigationalCell transplant therapies
Azercabtagene zapreleucel: Overview.
- Also known as
- Adult allogeneic CD4+ and CD8+ enriched T cells transduced with an anti-CD19 chimeric antigen receptor (CAR) that is site-specific integrated into the cellular genome. Adult allogeneic CD4+ and CD8+ enriched T cells, gene edited through the electroporati · Allogeneic gene-edited CD19-directed CAR T cells/azercabtagene zapreleucel
- Code names
- PBCAR-0191
Resolves to
Compound
What you can answer from here — as of April 23, 2025
Which companies are running trials of Azercabtagene zapreleucel, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account